Issue 3/2017
Content (7 Articles)
Potential drug targets and treatment of schizophrenia
Anil Kumar, Monu Yadav, Milind Parle, Sameer Dhingra, Dinesh K. Dhull
Mammalian target of rapamycin (mTOR) as a potential therapeutic target in various diseases
Avileen Kaur, Saurabh Sharma
Curcumin inhibits lipopolysaccharide (LPS)-induced endotoxemia and airway inflammation through modulation of sequential release of inflammatory mediators (TNF-α and TGF-β1) in murine model
Asha Kumari, D. Dash, Rashmi Singh
Evaluation of the protective effect of pentoxifylline on carrageenan-induced chronic non-bacterial prostatitis in rats
Mahboobeh Hajighorbani, Mahmood Ahmadi-hamedani, Elaheh Shahab, Farzad Hayati, Khatereh Kafshdoozan, Keivan Keramati, Amin Hossein Amini
Curcumin protects dopaminergic neurons against inflammation-mediated damage and improves motor dysfunction induced by single intranigral lipopolysaccharide injection
Neha Sharma, Sheetal Sharma, Bimla Nehru
Sitagliptin and liraglutide reversed nigrostriatal degeneration of rodent brain in rotenone-induced Parkinson’s disease
Ghada A. Badawi, Mai A. Abd El Fattah, Hala F. Zaki, Moushira I. El Sayed